Orchestrating the Parkinson's disease microenvironment in 3D for pathogenesis study and therapeutic development

Area of Science:

• Neuroscience
• Biotechnology
• Regenerative Medicine

Background:

• Parkinson's disease (PD) incidence is rising globally, posing significant public health challenges.
• Traditional 2D cell cultures and animal models have limitations in fully replicating PD complexity.
• Need for advanced models that incorporate patient-specific data and 3D microenvironments.

Purpose of the Study:

• To review current understanding of PD etiology and pathogenesis relevant to 3D modeling.
• To systematically compare organoid, microfluidic, and 3D bioprinting platforms for PD research.
• To highlight the role of advanced 3D models in PD mechanistic studies and drug discovery.

Main Methods:

• Systematic literature review of recent advancements in 3D modeling for Parkinson's disease.
• Comparative analysis of organoid, microfluidic, and 3D bioprinting technologies.
• Evaluation of applications in PD mechanistic studies and therapeutic screening.

Main Results:

• 3D in vitro models provide superior recapitulation of PD pathology compared to traditional methods.
• Organoid, microfluidic, and 3D bioprinting platforms show promise for disease modeling and drug screening.
• These advanced models enhance understanding of PD pathogenesis and facilitate identification of novel therapeutic targets.

Conclusions:

• Advanced 3D in vitro models are crucial for overcoming limitations in current Parkinson's disease research.
• These technologies deepen mechanistic insights and accelerate the development of effective PD treatments.
• The integration of patient-specific characteristics into 3D models holds significant potential for personalized medicine approaches.